SCHEMBL7195343

SCHEMBL7195343

O=Cc1ccccc1OOc1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 2/20 0.49
HSD17B10 Q99714 2/20 0.49
PGR P06401 1/20 0.49
PTGS1 P23219 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 3/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTR1B P28222 2/20 0.44
SRC P12931 1/20 0.44
TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1199359 0.85 KMT2A (0.56) ALDH1A1HPGDHTTSMN1; SMN2GAA
SCHEMBL7196244 0.84 RAB9A (0.43) ALDH1A1HPGDSMN1; SMN2GAAHSD17B10
SCHEMBL7190029 0.82 EGFR (0.42) ALDH1A1HPGDSMN1; SMN2GAAHSD17B10
SCHEMBL4289478 0.82 HTR1B (0.59) ALDH1A1HPGDGAAHSD17B10PGR
SCHEMBL7190037 0.81 ALDH1A1 (0.50) ALDH1A1HPGDHTTSMN1; SMN2GAA
SCHEMBL7201515 0.79 MRGPRX4 (0.50) ALDH1A1HPGDSMN1; SMN2GAAHSD17B10
SCHEMBL9005 0.78 MEN1 (0.57) ALDH1A1HSD17B10KMT2AMEN1LMNA
SCHEMBL35849993 0.78 MEN1 (0.57) ALDH1A1HSD17B10KMT2AMEN1LMNA
Hydrochloric Acid SCHEMBL10384676 0.76 MEN1 (0.55) ALDH1A1HSD17B10KMT2AMEN1LMNA
SCHEMBL3115624 0.76 MEN1 (0.55) ALDH1A1HSD17B10KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 ALDH1A1 1488/4885HPGD 3530/4885HTT 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.